Loading…
Medistep Healthcare (MEDISTEP)₹18.90+5.29%Personal Care
In the Mar 2026 quarter (standalone), Medistep Healthcare reported sales of ₹35.84 Cr, up 25.8% from Mar 2025, and net profit of ₹3.02 Cr, up 22.3% year on year. For the year to Mar 2026, sales were ₹70.99 Cr and net profit ₹5.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 21.30 | 28.48 | 35.14 | 35.84 |
| Expenses | 18.94 | 25.10 | 31.06 | 31.48 |
| Operating Profit | 2.28 | 3.30 | 3.97 | 4.26 |
| OPM % | 10.7% | 11.6% | 11.3% | 11.9% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 0.03 | 0.02 | 0.00 | 0.26 |
| Depreciation | 0.03 | 0.01 | 0.02 | 0.02 |
| Profit before tax | 2.24 | 3.27 | 3.96 | 4.02 |
| Tax % | 25.3% | 25.3% | 25.2% | 25.0% |
| Net Profit | 1.68 | 2.47 | 2.98 | 3.02 |
| EPS (Rs) | 1.62 | 2.36 | 2.10 | 2.13 |
| Mar 2024 9m | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 31.65 | 49.80 | 70.99 |
| Expenses | 27.63 | 44.05 | 62.57 |
| Operating Profit | 3.95 | 5.60 | 8.23 |
| OPM % | 12.5% | 11.3% | 11.6% |
| Other Income | 0.00 | 0.00 | 0.01 |
| Interest | 0.07 | 0.05 | 0.26 |
| Depreciation | 0.01 | 0.02 | 0.04 |
| Profit before tax | 3.88 | 5.53 | 7.97 |
| Tax % | 25.2% | 25.0% | 25.1% |
| Net Profit | 2.92 | 4.15 | 5.99 |
| EPS (Rs) | 5.96 | 3.97 | 4.22 |
| Dividend payout % | 0.0% | 0.0% | 0.0% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 4.91 | 10.48 | 14.23 |
| Reserves | 6.79 | 6.38 | 23.61 |
| Borrowings | 0.32 | 0.65 | 5.19 |
| Other Liabilities | 2.95 | 5.52 | 7.31 |
| Total Liabilities | 14.97 | 23.03 | 50.34 |
| Fixed Assets | 0.16 | 0.13 | 0.13 |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| Other Assets | 14.81 | 22.90 | 50.21 |
| Inventories | 0.92 | 1.09 | 6.19 |
| Trade receivables | 13.76 | 20.13 | 39.45 |
| Cash & equivalents | 0.00 | 1.30 | 0.60 |
| Total Assets | 14.97 | 23.03 | 50.34 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from operating activity | −7.12 | 0.03 | −19.49 |
| Cash from investing activity | −0.14 | 0.00 | 0.00 |
| Cash from financing activity | 7.22 | 1.27 | 18.75 |
| Net cash flow | −0.01 | 1.29 | −0.69 |
| Capex | 0.16 | 0.00 | 0.02 |
| Free cash flow | −7.24 | 0.01 | −19.45 |
| CFO / OP % | −180.0% | 1.0% | −224.0% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor days | 158 | 147 | 202 |
| Inventory days | 11 | 8 | 35 |
| Days payable | 19 | 21 | 22 |
| Cash conversion cycle | 152 | 137 | 218 |
| Working capital days | 134 | 113 | 191 |
| ROCE % | — | 37.8% | 27.2% |
For the Mar 2026 quarter, Medistep Healthcare reported sales of ₹35.84 Cr, up 25.8% year on year and net profit of ₹3.02 Cr, up 22.3% year on year. The operating margin was 11.9%.
Medistep Healthcare's sales for the year to Mar 2026 were ₹70.99 Cr.
Net profit for the year to Mar 2026 was ₹5.99 Cr. Earnings per share over the same trailing period were ₹4.22.
Medistep Healthcare reported borrowings of ₹5.19 Cr at Mar 2026, against cash and equivalents of ₹0.60 Cr.
Cash from operations was −₹19.49 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹19.45 Cr.